• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

21.98 +0.46 (+2.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 283,773
Open 21.50
Bid (Size) 21.96 (600)
Ask (Size) 21.99 (500)
Prev. Close 21.52
Today's Range 21.41 - 22.07
52wk Range 16.64 - 31.26
Shares Outstanding 48,081,433
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stands Out as a Quality Investing Candidate ↗
August 15, 2026
Via Chartmill
News headline image
Amphastar (AMPH) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
New product launches drove 5% revenue growth and margin expansion. 
Via The Motley Fool
Topics Earnings

Performance

YTD
-16.9%
-16.9%
1 Month
+14.6%
+14.6%
3 Month
+16.9%
+16.9%
6 Month
-20.2%
-20.2%
1 Year
-26.3%
-26.3%

More News

Read More
News headline image
The Top 5 Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings Call
August 13, 2026
Via StockStory
Topics Earnings
News headline image
AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results
August 07, 2026
Via StockStory
Amphastar Pharmaceuticals (NASDAQ:AMPH) Beats Q2 Earnings Estimates, Shares Rise After Hours ↗
August 06, 2026
Via Chartmill
Amphastar Pharmaceuticals (NASDAQ:AMPH) Screens as a High-Quality Stock with Deep Value Appeal ↗
July 18, 2026
Via Chartmill
Amphastar (AMPH) Q1 2026 Earnings Transcript ↗
May 07, 2026
Via The Motley Fool
News headline image
Amphastar Pharmaceuticals Q2 Earnings Call Highlights ↗
August 06, 2026
Via MarketBeat
Topics Earnings
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026
August 06, 2026
Via StockStory
News headline image
What To Expect From Amphastar Pharmaceuticals’s (AMPH) Q2 Earnings
August 04, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
1 Value Stock to Own for Decades and 2 Facing Challenges
August 03, 2026
Via StockStory
News headline image
1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds
July 28, 2026
Via StockStory
News headline image
3 Reasons AMPH is Risky and 1 Stock to Buy Instead
July 28, 2026
Via StockStory
Topics Supply Chain
News headline image
3 Stocks Under $50 We Keep Off Our Radar
July 22, 2026
Via StockStory
Topics Energy
News headline image
1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges
July 10, 2026
Via StockStory
News headline image
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
June 12, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth ↗
June 10, 2026
Via MarketBeat
News headline image
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag ↗
June 04, 2026
Via MarketBeat
News headline image
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
May 27, 2026
Via ACCESS Newswire
News headline image
3 Stocks Under $50 with Open Questions
May 26, 2026
Via StockStory
News headline image
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
May 14, 2026
Via StockStory
News headline image
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook ↗
May 14, 2026
Via MarketBeat
News headline image
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call
May 14, 2026
Via StockStory
Topics Earnings
News headline image
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment
May 12, 2026
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock Drops
May 07, 2026
Via StockStory
Topics Artificial Intelligence

Frequently Asked Questions

Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 21.98
When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 08/25/26 04:00 PM ET
What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 1.06B
How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
Amphastar Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap